Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using ... Late-breaking 28-week data from the Open Label Extension ...
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of ...
Financials Third Quarter 2024 Financial Results Note on International Financial Reporting Standards (IFRS) Pharvaris is a Foreign Private Issuer and prepares and reports consolidated financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback